CAS 79350-37-1 Pharmaceutical Cefixime Powder Raw Material Cefixime

• Customization: Available
• CAS No.: 79350-37-1
• Formula: C16h15n5o7s2
• Model NO.: QS-cefixime
• EINECS: 616-684-4
• Packaging Material: Metal
• Storage Method: Normal
• Shelf Life: >12 Months
• Nutrient Composition: Cefixime
• Resource: Cefixime
• The content of active substances: >99%
• Certification: GMP, Hse, ISO 9001, USP, Bp
• Product Name: Cefixime
• Name: Cefixime Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: 99%
• Test Method: HPLC
• Mf: C16h15n5o7s2
• Density: 1.85 g/cm3
• Melting Point: 218-225°c
• Boiling Point: 200°c
• MW: 507.5g/Mol
• Application: Pharmaceutical
• Refractive Index: 1.811
• Transport Package: Negotiable
• Specification: Negotiable
• Trademark: QS-cefixime
• Origin: Shaanxi Xi′an
• Production Capacity: 2000kg/Month

Product Description

CAS 79350-37-1 Pharmaceutical cefixime Powder  Raw Material cefixime

Product Description

Product Details

Product Name	cefixime
CAS NO	79350-37-1
Molecular Formula	C16H15N5O7S2
Molecular Weight	507.5g/mol
Appearance	White Powder

Cefixime is a third-generation oral cephalosporin antibiotic that appears as a white to pale yellow crystalline powder. This drug has broad-spectrum antibacterial activity, is stable against β - lactases, and is suitable for treating various bacterial infections, including respiratory, urinary, and ear, nose, and throat infections. Cefoxime preparations are commonly found in tablets, capsules, and dry suspensions, and are widely used in clinical practice due to their good oral absorption.

Application&Function

Cefoxime exerts bactericidal effects by inhibiting the synthesis of bacterial cell walls, mainly targeting Gram positive and Gram negative bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, Escherichia coli, and Neisseria gonorrhoeae. Its characteristics are wide antibacterial spectrum, high bioavailability, and stability against most β - lactams. Clinically, it is mainly used to treat otitis media, bronchitis, pneumonia, urinary tract infections, gonorrhea, and simple cystitis. Cefoxime has fewer side effects and is commonly associated with mild gastrointestinal reactions such as diarrhea or nausea. Due to its good safety and efficacy, this drug is listed on the World Health Organization (WHO) Essential Medicines List and is an important choice for treating common infections.

Specification